247 related articles for article (PubMed ID: 28459565)
1. Membrane Disruption Mechanism of a Prion Peptide (106-126) Investigated by Atomic Force Microscopy, Raman and Electron Paramagnetic Resonance Spectroscopy.
Pan J; Sahoo PK; Dalzini A; Hayati Z; Aryal CM; Teng P; Cai J; Rodriguez Gutierrez H; Song L
J Phys Chem B; 2017 May; 121(19):5058-5071. PubMed ID: 28459565
[TBL] [Abstract][Full Text] [Related]
2. PrP106-126 peptide disrupts lipid membranes: influence of C-terminal amidation.
Zheng W; Wang L; Hong Y; Sha Y
Biochem Biophys Res Commun; 2009 Feb; 379(2):298-303. PubMed ID: 19103159
[TBL] [Abstract][Full Text] [Related]
3. Structural diversity and initial oligomerization of PrP106-126 studied by replica-exchange and conventional molecular dynamics simulations.
Ning L; Guo J; Bai Q; Jin N; Liu H; Yao X
PLoS One; 2014; 9(2):e87266. PubMed ID: 24586266
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human prion neuropeptide PrP106-126 aggregation by hexacoordinated ruthenium complexes.
Wang X; Zhang B; Zhao C; Wang Y; He L; Cui M; Zhu X; Du W
J Inorg Biochem; 2013 Nov; 128():1-10. PubMed ID: 23911565
[TBL] [Abstract][Full Text] [Related]
5. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126.
Bergström AL; Chabry J; Bastholm L; Heegaard PM
Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142
[TBL] [Abstract][Full Text] [Related]
6. Effects of lipid composition and phase on the membrane interaction of the prion peptide 106-126 amide.
Zhong J; Yang C; Zheng W; Huang L; Hong Y; Wang L; Sha Y
Biophys J; 2009 Jun; 96(11):4610-21. PubMed ID: 19486683
[TBL] [Abstract][Full Text] [Related]
7. The role of calcium ions in the interactions of PrP106-126 amide with model membranes.
Zhong J; Yang C; Zheng W; Huang L; Hong Y; Wang L; Sha Y
Colloids Surf B Biointerfaces; 2010 May; 77(1):40-6. PubMed ID: 20116976
[TBL] [Abstract][Full Text] [Related]
8. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Jobling MF; Huang X; Stewart LR; Barnham KJ; Curtain C; Volitakis I; Perugini M; White AR; Cherny RA; Masters CL; Barrow CJ; Collins SJ; Bush AI; Cappai R
Biochemistry; 2001 Jul; 40(27):8073-84. PubMed ID: 11434776
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.
Walsh P; Vanderlee G; Yau J; Campeau J; Sim VL; Yip CM; Sharpe S
J Biol Chem; 2014 Apr; 289(15):10419-10430. PubMed ID: 24554723
[TBL] [Abstract][Full Text] [Related]
10. PrP106-126 amide causes the semi-penetrated poration in the supported lipid bilayers.
Zhong J; Zheng W; Huang L; Hong Y; Wang L; Qiu Y; Sha Y
Biochim Biophys Acta; 2007 Jun; 1768(6):1420-9. PubMed ID: 17451641
[TBL] [Abstract][Full Text] [Related]
11. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
[TBL] [Abstract][Full Text] [Related]
13. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
Kawahara M; Koyama H; Nagata T; Sadakane Y
Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
[TBL] [Abstract][Full Text] [Related]
14. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
[TBL] [Abstract][Full Text] [Related]
15. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation.
Corsaro A; Thellung S; Villa V; Principe DR; Paludi D; Arena S; Millo E; Schettini D; Damonte G; Aceto A; Schettini G; Florio T
Ann N Y Acad Sci; 2003 Dec; 1010():610-22. PubMed ID: 15033801
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro.
Liu YH; Han YL; Song J; Wang Y; Jing YY; Shi Q; Tian C; Wang ZY; Li CP; Han J; Dong XP
Int J Biochem Cell Biol; 2011 May; 43(5):768-74. PubMed ID: 21296677
[TBL] [Abstract][Full Text] [Related]
17. Hetero-oligomeric Amyloid Assembly and Mechanism: Prion Fragment PrP(106-126) Catalyzes the Islet Amyloid Polypeptide β-Hairpin.
Ilitchev AI; Giammona MJ; Olivas C; Claud SL; Lazar Cantrell KL; Wu C; Buratto SK; Bowers MT
J Am Chem Soc; 2018 Aug; 140(30):9685-9695. PubMed ID: 29989407
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics study of the fibril elongation of the prion protein fragment PrP106-126.
Zhang Y; Zhao X; Wang PY
J Theor Biol; 2007 Mar; 245(2):238-42. PubMed ID: 17166520
[TBL] [Abstract][Full Text] [Related]
19. The prion fragment PrP106-127 adopts a secondary structure typical of aggregated fibrils in langmuir monolayers of brain lipid extract.
Sandrino B; Jochelavicius K; Volpati D; Barbosa SC; Nobre TM; Oliveira ON
Chem Phys Lipids; 2020 Aug; 230():104930. PubMed ID: 32470442
[TBL] [Abstract][Full Text] [Related]
20. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
Walsh P; Yau J; Simonetti K; Sharpe S
Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
